Hexa‐D‐arginine treatment increases 7B2•PC2 activity in hyp‐mouse osteoblasts and rescues the HYP phenotype

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2013-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jbmr.1738PMID 22886699PMCID PMC3523095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas

  2012cited by this paper
• On the discovery of precursor processing.

  2011cited by this paper
• The proprotein convertases, 20 years later.

  2011cited by this paper
• Dynamic Modulation of Prohormone Convertase 2 (PC2)-mediated Precursor Processing by 7B2 Protein

  2011cited by this paper
• Regulation of 7B2 mRNA translation: dissecting the role of its 5'-untranslated region.

  2011cited by this paper
• Dynamic modulation of PC2-mediated precursor processing by 7B2: preferential effect on glucagon synthesis

  2011cited by this paper
• The Biological Function of DMP-1 in Osteocyte Maturation Is Mediated by Its 57-kDa C-terminal Fragment

  2010cited by this paper
• Failure to Process Dentin Matrix Protein 1 (DMP1) into Fragments Leads to Its Loss of Function in Osteogenesis*

  2010cited by this paper
• Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model

  2009cited by this paper
• MMP2-cleavage of DMP1 generates a bioactive peptide promoting differentiation of dental pulp stem/progenitor cell.

  2009cited by this paper
• Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation

  2009cited by this paper
• Therapeutic Effects of Anti‐FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia

  2009influential reference
• Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.

  2009cited by this paper
• Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis.

  2008cited by this paper
• Studies of the DMP1 57-kDa Functional Domain both in vivo and in vitro

  2008cited by this paper
• Anti‐FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23

  2008cited by this paper
• Overexpression of Scg5 increases enzymatic activity of PCSK2 and is inversely correlated with body weight in congenic mice

  2008cited by this paper
• Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.

  2008cited by this paper
• Rescue of odontogenesis in Dmp1-deficient mice by targeted re-expression of DMP1 reveals roles for DMP1 in early odontogenesis and dentin apposition in vivo.

  2007cited by this paper
• SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas

  2007cited by this paper
• Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism

  2006cited by this paper
• Differences of pancreatic expression of 7B2 between C57BL/6J and C3H/HeJ mice and genetic polymorphisms at its locus (Sgne1).

  2006cited by this paper
• Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis

  2006cited by this paper
• DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis

  2006cited by this paper
• Differences of Pancreatic Expression of 7 B 2 Between C 57 BL / 6 J and C 3 H / HeJ Mice and Genetic Polymorphisms at its locus ( Sgne 1 )

  2006cited by this paper
• Pathogenic role of Fgf23 in Hyp mice.

  2006influential reference
• Overexpression of Human PHEX Under the Human β‐Actin Promoter Does Not Fully Rescue the Hyp Mouse Phenotype

  2005cited by this paper
• Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed.

  2005cited by this paper
• An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

  2005influential reference
• A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification

  2005cited by this paper
• A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.

  2005influential reference
• A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.

  2005cited by this paper
• Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

  2004influential reference
• FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

  2004influential reference
• Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.

  2004cited by this paper
• Evidence for abnormal translational regulation of renal 25-hydroxyvitamin D-1alpha-hydroxylase activity in the hyp-mouse.

  2004cited by this paper
• FGF23 is processed by proprotein convertases but not by PHEX.

  2004cited by this paper
• Bone Morphogenetic Protein-1/Tolloid-like Proteinases Process Dentin Matrix Protein-1*

  2004cited by this paper
• Evidence for the Proteolytic Processing of Dentin Matrix Protein 1

  2003cited by this paper
• Dentin Matrix Protein 1 Initiates Hydroxyapatite Formation In Vitro

  2003cited by this paper
• Paired Basic/Furin-like Proprotein Convertase Cleavage of Pro-BMP-1 in the trans-Golgi Network*

  2003cited by this paper
• Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX*

  2003influential reference
• The Autosomal Dominant Hypophosphatemic Rickets R176Q Mutation in Fibroblast Growth Factor 23 Resists Proteolytic Cleavage and Enhances in Vivo Biological Potency*

  2003cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Dual Functional Roles of Dentin Matrix Protein 1

  2003cited by this paper
• Overexpression of Phex in Osteoblasts Fails to Rescue the Hyp Mouse Phenotype*

  2002cited by this paper
• Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

  2002cited by this paper
• Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression.

  2002cited by this paper
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001cited by this paper
• Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.

  2001cited by this paper
• Polyarginines Are Potent Furin Inhibitors*

  2000cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000influential reference
• Processing and Sorting of the Prohormone Convertase 2 Propeptide*

  2000cited by this paper
• Coordinate regulation of neuroendocrine convertase PC2 and peptide 7B2 in P19 neurons.

  2000cited by this paper
• The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease.

  1999cited by this paper
• Intrinsic mineralization defect in Hyp mouse osteoblasts.

  1998cited by this paper
• Neuroendocrine Protein 7B2 Is Essential for Proteolytic Conversion and Activation of Proprotein Convertase 2 in Vivo

  1998cited by this paper
• Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP).

  1997cited by this paper
• Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets.

  1997cited by this paper
• Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice.

  1997cited by this paper
• Human Prohormone Convertase 3 Gene: Exon-Intron Organization and Molecular Scanning for Mutations in Japanese Subjects With NIDDM

  1996cited by this paper
• cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone.

  1996cited by this paper
• 7B2 Is a Specific Intracellular Binding Protein of the Prohormone Convertase PC2

  1995cited by this paper
• 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity

  1995cited by this paper
• A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets

  1995cited by this paper
• Neuroendocrine-specific Expression of the Human Prohormone Convertase 1 Gene

  1995cited by this paper
• 7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretory pathway.

  1994cited by this paper
• Abnormal regulation of renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the X-linked hypophosphatemic mouse.

  1983cited by this paper
• The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.

  1982cited by this paper
• Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.

  1980cited by this paper

• Development and Prospects of Furin Inhibitors for Therapeutic Applications

  2024cites this paper
• Multiomics profiling reveals VDR as a central regulator of mesenchymal stem cell senescence with a known association with osteoporosis after high-fat diet exposure

  2024cites this paper
• Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs.

  2024cites this paper
• FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice

  2023cites this paper
• Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation

  2023cites this paper
• PHEXL222P Mutation Increases Phex Expression in a New ENU Mouse Model for XLH Disease

  2022cites this paper
• Phosphatonins: From Discovery to Therapeutics.

  2022cites this paper
• The regulation of FGF23 under physiological and pathophysiological conditions

  2022cites this paper
• Function of PHEX mutations p.Glu145* and p.Trp749Arg in families with X-linked hypophosphatemic rickets by the negative regulation mechanism on FGF23 promoter transcription

  2022cites this paper
• Upstream Regulators of Fibroblast Growth Factor 23

  2021cites this paper
• Disorders of Mineral Metabolism II. Abnormalities of Mineral Homeostasis in the Newborn, Infant, Child, and Adolescent

  2021cites this paper
• FGF23 as a drug target

  2021cites this paper
• The Causes of Hypo- and Hyperphosphatemia in Humans

  2020cites this paper
• Fibroblast growth factor 23

  2020cites this paper
• Bibliography

  2020cites this paper
• Mechanisms of phosphate transport

  2019cites this paper
• Regulation of fibroblast growth factor 23 (FGF23) in health and disease

  2019cites this paper
• FGF23 and Bone and Mineral Metabolism.

  2019cites this paper
• Management of X-linked hypophosphatemia in adults.

  2019cites this paper
• Animal Models of Phosphorus Homeostasis

  2019cites this paper
• FGF23 and its role in X-linked hypophosphatemia-related morbidity

  2019cites this paper
• Inherited Disorders of Calcium, Phosphate, and Magnesium

  2019cites this paper
• Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

  2019cites this paper
• FGF23, Hypophosphatemia, and Emerging Treatments

  2019cites this paper
• X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.

  2018cites this paper
• Chapter 40 – Heritable Renal Phosphate Wasting Disorders

  2018cites this paper
• Mechanisms and Regulation of Intestinal Phosphate Absorption.

  2018cites this paper
• Hypertension is a characteristic complication of X-linked hypophosphatemia.

  2017cites this paper
• Fibroblast Growth Factor 23-Mediated Bone Disease.

  2017cites this paper
• FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts

  2017cites this paper
• A novel auditory ossicles membrane and the development of conductive hearing loss in Dmp1-null mice.

  2017cites this paper
• Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition.

  2016cites this paper
• Family with sequence similarity member 20C is the primary but not the only kinase for the small‐integrin‐binding ligand N‐linked glycoproteins in bone

  2016cites this paper
• Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23.

  2016cites this paper
• Fibroblast Growth Factor 23

  2015cites this paper
• A unified model for bone-renal mineral and energy metabolism.

  2015influential citation
• Intestinal Depletion of NaPi‐IIb/Slc34a2 in Mice: Renal and Hormonal Adaptation

  2015cites this paper
• The role of furin in bone homeostasis

  2015cites this paper
• FGF23 Is Endogenously Phosphorylated in Bone Cells

  2015cites this paper
• FGF 23 in acute kidney injury

  2014cites this paper
• Hypophosphatemic rickets due to perturbations in renal tubular function

  2014cites this paper
• Therapeutic management of hypophosphatemic rickets from infancy to adulthood

  2014cites this paper
• PHEX Mimetic (SPR4-Peptide) Corrects and Improves HYP and Wild Type Mice Energy-Metabolism

  2014cites this paper
• Dysregulated Gene Expression in the Primary Osteoblasts and Osteocytes Isolated from Hypophosphatemic Hyp Mice

  2014cites this paper
• Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23

  2014cites this paper
• Fibroblast growth factor 23

  2014cites this paper
• The rachitic tooth.

  2014cites this paper
• Fibroblast growth factor 23 in acute kidney injury

  2014cites this paper
• Hypophosphatemic Rickets: Revealing Novel Control Points for Phosphate Homeostasis

  2014cites this paper
• Dmp1 Regulates Osteocyte Function Via Wnt/β-Catenin Signaling Pathway

  2014cites this paper
• Iron and fibroblast growth factor 23 in X-linked hypophosphatemia.

  2014cites this paper
• Erratum: Hexa‐D‐arginine treatment increases 7B2•PC2 activity in hyp‐mouse osteoblasts and rescues the HYP phenotype

  2013cites this paper
• Genetische Störungen der Knochenmineralisation

  2013cites this paper
• Fibrous Dysplasia and Fibroblast Growth Factor-23 Regulation

  2013cites this paper
• Insights from genetic disorders of phosphate homeostasis.

  2013cites this paper
• Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.

  2013cites this paper
• Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia.

  2013cites this paper
• Dietary phosphate: the challenges of exploring its role in FGF23 regulation.

  2013cites this paper
• Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.

  2012cites this paper
• The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled

  2012cites this paper
• Dynamic Modulation of Prohormone Convertase 2 (PC2)-mediated Precursor Processing by 7B2 Protein

  2011cites this paper